VYCO · Vycor Medical Inc · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred losses since its inception, including a net loss of $2,180 for the six months ended June 30, 2026 and has not generated sufficient positive cash flows from operations. As of June 30, 2026 the Company had a working capital deficiency of $4,294,543 which includes related party liabilities of $3,800,538. These conditions, among others, raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2022-09-30 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of September 30, 2022 |
Common stock
|
535,714 |
| 2022-06-30 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of June 30, 2022 |
Common stock
|
535,714 |
| 2022-03-31 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of March 31, 2022 |
Common stock
|
535,714 |
| 2021-09-30 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of June 30, 2021 |
Common stock
|
535,714 |
| 2021-09-30 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of June 30, 2021 |
Common stock
|
535,714 |
| 2021-06-30 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of June 30, 2021 |
Common stock
|
535,714 |
| 2021-04-01 | GIRGENTI STEVEN |
Director |
Discretionary↑
|
Vycor Medical Inc. Common Stock par value $0.0001
|
33 |
| 2021-03-31 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of March 31, 2021. |
Common stock
|
535,714 |
| 2021-03-31 | Rush Lowell |
Director |
Other↑
|
Vycor Medical Inc. Common Stock par value $0.001
|
33,333 |
| 2021-01-01 | GIRGENTI STEVEN |
Director |
Discretionary↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.0001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.0001
|
33 |
| 2020-12-31 | Rush Lowell |
Director |
Other↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.001
|
33,333 |
| 2020-12-31 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common stock (Direct)
Shares issued on account of accrued consultancy fees as of September 30, 2020. |
Common stock
|
535,714 |
| 2020-10-01 | GIRGENTI STEVEN |
Director |
Discretionary↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.0001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.0001
|
33,333 |
| 2020-09-30 | Rush Lowell |
Director |
Other↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.001
|
33,333 |
| 2020-09-30 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common Stock (Direct)
Shares issued on account of accrued consultancy fees as of September 30, 2020. |
Common Stock
|
535,714 |
| 2020-07-01 | GIRGENTI STEVEN |
Director |
Discretionary↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.0001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.0001
|
33,333 |
| 2020-06-30 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common Stock (Direct)
Shares issued on account of accrued consultancy fees as of June 30, 2020. |
Common Stock
|
535,714 |
| 2020-06-30 | Rush Lowell |
Director |
Other↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.001
|
33,333 |
| 2020-06-30 | Bronsther Oscar |
Director |
Other↑
Filing footnotes — Vycor Medical Inc. Common Stock Par Value $0.0001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock Par Value $0.0001
|
33,333 |
| 2020-04-01 | GIRGENTI STEVEN |
Director |
Discretionary↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.0001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.0001
|
33,333 |
| 2020-03-31 | Bronsther Oscar |
Director |
Other↑
Filing footnotes — Vycor Medical Inc. Common Stock Par Value $0.0001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock Par Value $0.0001
|
33,333 |
| 2020-03-31 | Rush Lowell |
Director |
Other↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.001
|
33,333 |
| 2020-03-31 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD |
10% Owner |
Other↑
Filing footnotes — Common Stock (Direct)
Shares issued on account of accrued consultancy fees as of March 31, 2020. |
Common Stock
|
535,714 |
| 2020-01-01 | GIRGENTI STEVEN |
Director |
Discretionary↑
Filing footnotes — Vycor Medical Inc. Common Stock par value $0.0001 (Direct)
Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. |
Vycor Medical Inc. Common Stock par value $0.0001
|
33,333 |